Selectins as potential targets of therapeutic intervention in inflammatory diseases.
Welply
J K
JK
Monsanto Corporation, Department of Immunology, St. Louis, MO 63167.
Keene
J L
JL
Schmuke
J J
JJ
Howard
S C
SC
D000595:Amino Acid Sequence; D002240:Carbohydrate Sequence; D015815:Cell Adhesion Molecules / Q000032:analysis / Q000737:chemistry* / Q000235:genetics; D015195:Drug Design; D019040:E-Selectin; D007249:Inflammation / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D019041:L-Selectin; D008070:Lipopolysaccharides / Q000627:therapeutic use; D008969:Molecular Sequence Data; D009844:Oligosaccharides / Q000737:chemistry; D019007:P-Selectin; D010980:Platelet Membrane Glycoproteins / Q000032:analysis / Q000037:antagonists & inhibitors / Q000737:chemistry*
D015815:Cell Adhesion Molecules; D019040:E-Selectin; D008070:Lipopolysaccharides; D009844:Oligosaccharides; D019007:P-Selectin; D010980:Platelet Membrane Glycoproteins; D019041:L-Selectin